Evidence map›Paper›PMID 41229761›Full record

ArticleJournal of thoracic disease2025

Perioperative changing patterns of systemic immune-inflammatory index (SII) and outcomes in stage I-III non-small cell lung cancer: a retrospective cohort study.

Yanling Miao, Chunxia Li, Yongrui Zhang, Zhenhui Li, Yanli Li, Yijia Sun, Xia Zheng, Jing Ai, Lizhu Liu, Ruimin You and 3 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yanling Miao *Department of Geriatric Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Chunxia Li *Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
Yongrui Zhang *Department of Clinical Laboratory Medicine, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Zhenhui LiDepartment of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Yanli LiDepartment of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Yijia SunDepartment of Geriatric Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Xia ZhengDepartment of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Jing AiDepartment of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Lizhu LiuDepartment of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Ruimin YouDepartment of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Changling TuDepartment of Geriatric Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Tao ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.
Xiaobo ChenFirst Department of Thoracic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The systemic immune-inflammation index (SII) has shown prognostic value in cancers, but its dynamic perioperative changes and implications in non-small cell lung cancer (NSCLC) remain underexplored. This study investigates the prognostic significance of perioperative SII changing patterns in resectable stage I-III NSCLC. Methods: A retrospective cohort of 2,489 patients undergoing curative resection for stage I-III NSCLC [2013-2018] was analyzed. SII (neutrophils × platelets/lymphocytes) was measured preoperatively, postoperatively, and serially over 12 months. Restricted cubic splines (RCS) and X-tile determined optimal SII cutoffs. Latent class growth mixed models (LCGMMs) identified longitudinal SII trajectories. Associations with recurrence-free survival (RFS) and overall survival (OS) were evaluated using Cox models. Results: High preoperative SII (>50.4), elevated postoperative/preoperative SII ratio (>2.3), and persistent postoperative SII elevation independently predicted worse RFS [adjusted hazard ratios (HRs): 1.37, 1.76, and 2.46, respectively; all P<0.05]. Three distinct SII trajectories emerged: slow-decreasing (93.7%, 3-year RFS 74.4%), sharp-decreasing (4.0%, 3-year RFS 42.0%), and rising (2.31%, 3-year RFS 43.2%). The rising trajectory group exhibited bimodal SII peaks at 2-3 and 8-12 months postoperatively, correlating with a 2.46-fold increased recurrence risk [95% confidence interval (CI): 1.50-4.03; P<0.001] compared to the slow-decreasing group, even after adjusting for preoperative SII and clinicopathological factors. Conclusions: Perioperative SII changing patterns provide critical prognostic insights beyond static measurements and demonstrate potential for predicting postoperative recurrence risk in stage I-III NSCLC patients.

Indexed as

Non-small cell lung cancer (NSCLC)prognosisrecurrence-free survival (RFS)systemic immune-inflammatory index (SII)trajectories

Identifiers

PMID41229761
PMCPMC12603539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.